𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression and purification of cGMP grade NY-ESO-1 for clinical trials

✍ Scribed by Adam J. Lowe; Cameron L. Bardliving; Chung-Jr Huang; Leonardo M. Teixeira; Leonardo M. Damasceno; Kyle A. Anderson; Gerd Ritter; Lloyd J. Old; Carl A. Batt

Book ID
101764637
Publisher
American Institute of Chemical Engineers
Year
2011
Tongue
English
Weight
325 KB
Volume
27
Category
Article
ISSN
8756-7938

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Heterogeneous expression of GAGE, NY-ESO
Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy
✍ Argun Akcakanat; Tatsuo Kanda; Tadashi Tanabe; Shintarou Komukai; Kazuhito Yajim πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 421 KB

## Abstract Cancer/testis antigens (CTAs) elicit immune response in cancer patients and are therefore targets of immunotherapy. Current information on CTA expression is primarily based on mRNA assays and little is known about their expression at the protein level. The objectives of our study are to

A phase I clinical trial of interferon-b
A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy
✍ Toshihiko Wakabayashi; Atsushi Natsume; Yoshio Hashizume; Masazumi Fujii; Masaak πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 731 KB

## Abstract ## Background High‐grade gliomas are highly lethal neoplasms representing approximately 20% of all intracranial tumors. Cationic liposome‐mediated interferon‐beta (__IFN‐__Ξ²) gene transfer has been found to induce regression of experimental glioma. We have previously performed a pilot